New updates have been reported about Breakthrough Properties (PC:BREAK)
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Breakthrough Properties has announced a strategic partnership with Eli Lilly and Company to establish Lilly Gateway Labs at their newly developed site at 2300 Market Street, Philadelphia. This collaboration aims to provide biotechnology companies with immediate access to fully-equipped, science-ready lab suites. These facilities are designed to support innovative biotech firms by offering customizable plans, flexible lease terms, and predictable pricing for essential services. The labs, spanning 44,000 square feet, are equipped with premium scientific equipment and supported by on-site staff to facilitate research and development activities, minimizing upfront costs for participating companies.
The partnership leverages the strengths of both Breakthrough Properties and Eli Lilly, providing companies with access to a wealth of resources, including strategic guidance from Breakthrough’s Scientific Advisory Board and Lilly’s scientists and executives. This initiative is part of Breakthrough Properties’ broader strategy to reinforce Philadelphia as a leading hub for life sciences and innovation. The 2300 Market development, designed by KieranTimberlake, is strategically located near major academic institutions and offers a comprehensive R&D ecosystem, complete with lifestyle amenities and excellent transport links. Breakthrough Properties, a joint venture between Tishman Speyer and Bellco Capital, continues to focus on developing premier life science properties that foster scientific breakthroughs and innovation.